Cartesian Therapeutics Statistics
Total Valuation
RNAC has a market cap or net worth of $160.91 million. The enterprise value is $48.45 million.
Important Dates
The last earnings date was Monday, March 9, 2026, before market open.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAC has 26.51 million shares outstanding. The number of shares has increased by 49.63% in one year.
| Current Share Class | 26.51M |
| Shares Outstanding | 26.51M |
| Shares Change (YoY) | +49.63% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 57.66% |
| Owned by Institutions (%) | 21.31% |
| Float | 7.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 57.53 |
| Forward PS | 290.80 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.65
| Current Ratio | 8.65 |
| Quick Ratio | 8.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -14.82% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -30.80% |
| Weighted Average Cost of Capital (WACC) | 5.12% |
| Revenue Per Employee | $37,293 |
| Profits Per Employee | -$1.74M |
| Employee Count | 75 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.18% in the last 52 weeks. The beta is 0.23, so RNAC's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -62.18% |
| 50-Day Moving Average | 7.19 |
| 200-Day Moving Average | 9.04 |
| Relative Strength Index (RSI) | 37.53 |
| Average Volume (20 Days) | 298,783 |
Short Selling Information
The latest short interest is 2.15 million, so 8.11% of the outstanding shares have been sold short.
| Short Interest | 2.15M |
| Short Previous Month | 2.22M |
| Short % of Shares Out | 8.11% |
| Short % of Float | 28.33% |
| Short Ratio (days to cover) | 17.89 |
Income Statement
In the last 12 months, RNAC had revenue of $2.80 million and -$130.30 million in losses. Loss per share was -$5.02.
| Revenue | 2.80M |
| Gross Profit | -55.24M |
| Operating Income | -86.71M |
| Pretax Income | -139.50M |
| Net Income | -130.30M |
| EBITDA | -83.75M |
| EBIT | -86.71M |
| Loss Per Share | -$5.02 |
Full Income StatementBalance Sheet
The company has $125.14 million in cash and $12.68 million in debt, with a net cash position of $112.46 million or $4.24 per share.
| Cash & Cash Equivalents | 125.14M |
| Total Debt | 12.68M |
| Net Cash | 112.46M |
| Net Cash Per Share | $4.24 |
| Equity (Book Value) | -126.24M |
| Book Value Per Share | -4.85 |
| Working Capital | 114.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$73.94 million and capital expenditures -$5.45 million, giving a free cash flow of -$79.40 million.
| Operating Cash Flow | -73.94M |
| Capital Expenditures | -5.45M |
| Depreciation & Amortization | 2.96M |
| Net Borrowing | n/a |
| Free Cash Flow | -79.40M |
| FCF Per Share | -$3.00 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -3,099.93% |
| Pretax Margin | -4,987.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RNAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.63% |
| Shareholder Yield | -49.63% |
| Earnings Yield | -80.98% |
| FCF Yield | -49.34% |
Analyst Forecast
The average price target for RNAC is $35.00, which is 476.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.00 |
| Price Target Difference | 476.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 139.94% |
| EPS Growth Forecast (5Y) | -12.12% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
RNAC has an Altman Z-Score of -3.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.94 |
| Piotroski F-Score | 1 |
